UltiMed has been acquired by Levine Leichtman Capital Partners
TM Capital served as exclusive financial advisor to UltiMed, Inc., a portfolio company of LDI, Ltd., in its sale to an investment vehicle sub-managed by Levine Leichtman Capital Partners
TM Capital served as exclusive financial advisor to UltiMed, Inc., a portfolio company of LDI, Ltd., in its sale to an investment vehicle sub-managed by Levine Leichtman Capital Partners
TM Capital advised C.B. Fleet in completing an amended senior credit facility
TM Capital advised CorVista Health, Inc. in raising $65 million of Series C equity capital to advance its artificial intelligence-based cardiovascular diagnostic technology
TM Capital completed the sale of SteriGenics International, Inc. (NASDAQ) to Ion Beam Applications s.a. of Belgium for $214 million in cash